Page 827 - ACCCN's Critical Care Nursing

804 I N D E X

Intruder, The 91b refractory hypoxaemia management see left ventricular end-diastolic volume
intubation 384–386 refractory hypoxaemia management (LVEDV) 186
in children, for upper airway weaning from 403–404 left ventricular failure (LVF) 230, 230t
obstruction 687–688, 688f, automated 404 left ventricular stroke work index (LVSWI) 203
689t current recommendations 403 legal considerations, CPR and 672
cLMA and 383 difficult-to-wean patient 404 legislation 786
ETT 384–385, 384f methods 403–404 Levine scale, for heart murmur
complications of 387 prediction of 403 classification 191t
suctioning of 387 protocols 403–404, 406b–407b liaison nurse (LN), ICU 51–52
ICH and 472 research vignette 406b–407b limb movement assessment 433–434
preparation for 385 spontaneous breathing trials 403 motor tone 434
drugs 385 IPAP see inspiratory positive airway pressure peripheral reflex response 434
equipment 385 IPT see information processing theory spastic flexor 433–434
patient 385 IRB see Institutional Review Board withdrawal flexor 433–434
procedure 385–386 Irukandli envenomation 611 limb perfusion maintenance, IABP and 305
backwards, upwards, rightward pressure ischaemia, warm 789 limbic system 423–424, 786
manoeuvre 385 ischaemic Linton tube 520–521
cricoid pressure 385 heart disease 293 lipase 786–787
cuff management 385–386 stroke 463, 463t liver
ETT fixation 386 fibrinolytic therapy in 595b anatomy of 516–517
oral vs nasal 385 isolation precautions, respiratory pandemics cell injury mechanisms 517
tube position confirmation 386 and 362 disease of, in children 699–700
invasive cardiovascular monitoring ITBV see intrathoracic blood volume dysfunction 516–522
afterload 202–203 ITBVI see intrathoracic blood volume index assessment and 520, 520t
PVR 202–203 collaborative practice 520–522
SVR 202 extracorporeal liver support for 521–522
cardiac output see cardiac output J independent practice 519–520
contractility 186–187, 203 Jackson/Cubbin pressure area risk neurological considerations in 519–520
preload see preload calculator 112–113, 112t nursing practice 519
invasive device management 122b jugular venous oximetry 438–439 oesophageal balloon tamponade
invasive haemodynamic monitoring 195–196 jugular venous oxygenation (SjvO 2 ) for 520–521
invasive intra-arterial blood pressure 438–439 TIPS for 520–521
monitoring 198 junctional escape rhythms 258, 259f treatment of 520–522, 521t
invasive mechanical ventilation 392–404 justice 79–80, 92, 786 injury to 643
complications of 404, 405t acute 783
graphics 398–401 physiology of 516–517
flow vs time scalar 399, 400f K pregnancy physiology adaptation of 714
flow-volume loops 401 Katipo spider bite 606–607 viral hepatitis epidemiology 517
loops 399–401 ketamine 144–145, 145t liver failure 517–518
pressure vs time scalar 398–399, 399f kidneys 480, 480f acute see acute liver failure
pressure-volume loops 399–401, acute injury to 479, 783 acute-on-chronic see acute-on-chronic liver
400f–401f see also renal system failure
scalar parameters 398–399 kinetic bed therapy 114 chronic see chronic liver failure
volume vs time scalar 399, 400f knowledge, body of, development of 11–12 consequences of 518–519
indications for 392 Kolff dialyser 488f ascites 519
modes 395–398, 397t coagulopathy derangement 519
A/C 396, 397t haemodynamic instability 519
APRV 397t, 398 L HE 518
ATC 397t, 398 lactate production, shock and 540, 541t HPS 519
BiPAP 397t, 398 lactation HRS 518
CMV 396, 397t initiation of 737–738, 737b, 737f infection susceptibility 519
CPAP 396, 397t medications and 738 metabolic derangement 519
NAVA 397t, 398 LAD see left anterior descending artery respiratory compromise 519
pressure control 396 LAP see left atrial pressure monitoring variceal bleeding 519
PRVC 397t, 398 laryngeal mask airways 383, 384f varices 519
PSV 396, 397t larynx 327f see also hepatic failure
SIMV 396, 397t late diastolic heart sound (S4) 191 liver injury scale 643t
volume control 396 law liver transplantation 522–525
parameters for 392, 399f ethics and 80 contraindications for 522
expiratory sensitivity 392t, 395 statute 80 indications for 522
FiO 2 392–393, 392t laxatives 115–116 postoperative management 523–525
I:E ratio 392t, 393 lead placement blood loss 524
inspiratory flow and flow pattern 392t, for continuous cardiac monitoring 192 cardiovascular 524
393, 395f for 12-lead echocardiogram 193, 193f coagulopathy 524
inspiratory time 392t, 393 leaders, characteristics of 10 gastrointestinal 524
inspiratory trigger 392t, 393 leadership 7–11 graft dysfunction and rejection 524–525
peak airway pressure 392t, 395 clinical 10–11 initial nursing considerations 523–524
PEEP 392t, 393–394 management role and 29 late complications 525
pressure support 392t, 393 transformational 9–10, 788 neurological 524
respiratory rate 392t, 393 left anterior descending (LAD) artery 182, 183f, renal 524
rise time 392t, 394 217 respiratory 524
V T 392t, 393, 394t left atrial pressure (LAP) monitoring 202 recipient selection for 522
positioning 402–403 left coronary artery 182, 183f surgical techniques 522–523
head of bed elevation 402 left heart catheterisation 219–220 living donor 523
lateral 402 left ventricular dysfunction, post heart orthotopic 523
prone 402–403 transplantation 316–317, 318t split-liver transplantation 523, 523f